ClinicalTrials.gg
Sign In

Drug

INE963 clinical trials

Also written INE963.

studies test it
4
open now
1
in phase 3
0
first study started
2021

Keep track of what changes. Save the INE963 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Development codes

INE963
4

Studies by the year they started

4 studies that test it; most in 2024 (2)

Studies that test INE963, by start year
YearStudies
20211
20242
20251

By phase

A phase 1/2 study counts in both.

Phase 1
1
Phase 2
3

What it is tested for

Each study’s main condition, where its own words name it.

Malaria, Falciparum
3

Who runs them

Industry 4 · Other 0

Novartis Pharmaceuticals (4)

Often tested with

Tested in the same studies.

NITD 609 (2) · KLU156 (1)

Studies

Open first, then newest update. How each study uses INE963 is read from its arms, and is right about nine times in ten.

Testing it · 4

Codes

What other systems call INE963 · ClinicalTrials.gg INT002044

  • MeSH (NLM) C000729453INE963One source ClinicalTrials.gov

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.